Tech Company Financing Transactions
Rarity PBC Funding Round
On 10/29/2025, Rarity PBC raised $4.6 million in Seed funding from private investors.
Transaction Overview
Company Name
Announced On
10/29/2025
Transaction Type
Venture Equity
Amount
$4,600,000
Round
Seed
Investors
private investors (Lead Investor) (Steve Oliveira)
Proceeds Purpose
The proceeds from this financing will support Rarity's continued advancement of its ADA-SCID gene therapy toward commercial readiness.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Los Angeles, CA Undisclosed
USA
Los Angeles, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Rarity PBC is a Public Benefit Corporation advancing and commercializing life-saving genetic therapies for rare diseases. Guided by a mission to enable responsible development and broad patient reach, Rarity integrates scientific rigor with sustainable, mission-driven operations to deliver therapies beyond development and into the hands of patients worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Ayoub
Chief Scientific Officer
Katelyn Masiuk
Co-Founder
Roger Hollis
Co-Founder
Donald Kohn
Browse more venture capital transactions:
Prev: 10/29/2025: VeroSkills venture capital transaction
Next: 10/29/2025: Uluu venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs